Capital Investment Counsel (Colorado)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.52M Sell
2,935
-4
-0.1% -$4.09K 0.44% 74
2026
Q1
$2.7M Sell
2,939
-192
-6% -$195K 0.37% 81
2025
Q4
$3.36M Buy
3,131
+149
+5% +$142K 0.47% 74
2025
Q3
$2.28M Buy
2,982
+24
+0.8% +$17.9K 0.34% 79
2025
Q2
$2.31M Buy
2,958
+13
+0.4% +$10.1K 0.36% 77
2025
Q1
$2.43M Buy
2,945
+16
+0.5% +$13.3K 0.4% 77
2024
Q4
$2.26M Sell
2,929
-7
-0.2% -$5.8K 0.38% 74
2024
Q3
$2.6M Buy
2,936
+24
+0.8% +$21.6K 0.45% 71
2024
Q2
$2.64M Sell
2,912
-15
-0.5% -$12K 0.52% 69
2024
Q1
$2.28M Buy
+2,927
New +$2.08M 0.49% 65

Other funds holding LLY

Capital Investment Counsel (Colorado)'s LLY Position: Q2 2026 in Review

Capital Investment Counsel (Colorado) reduced its Eli Lilly (LLY) stake by 0.14% in Q2 2026, selling an estimated $4.09K and leaving 2,935 shares worth $3.52M. The position accounts for 0.44% of the portfolio, ranked #74.

Capital Investment Counsel (Colorado) first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Investment Counsel (Colorado) held 2,935 shares of Eli Lilly worth $3.52M as of Q2 2026.
  • Capital Investment Counsel (Colorado) sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.44% of Capital Investment Counsel (Colorado)'s portfolio in Q2 2026, its #74 holding.
  • Capital Investment Counsel (Colorado) first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q2 2026, filed 15 Jul 2026.